Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Harrison

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Leukemia|September 27, 2008
A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietinL J Russell, D G De Castro, M Griffiths, et al.
Leukemia|May 3, 2013
Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factorA Enshaei, C J Schwab, Z J Konn, et al.
Cancer Genetics and Cytogenetics|January 20, 2000
Multiplex fluorescence in situ hybridization and cross species color banding of a case of chronic myeloid leukemia in blastic crisis with a complex Philadelphia translocationC J Harrison, B Gibbons, F Yang, et al.
Leukemia|December 20, 2013
High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcomeL Chilton, G Buck, C J Harrison, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Leukemia|November 24, 2005
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trialsB E S Gibson, K Wheatley, I M Hann, et al.
Leukemia|May 1, 1992
Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemiaL M Secker-Walker, R Berger, P Fenaux, et al.
Leukemia|May 3, 2002
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyJ M Chessells, C J Harrison, H Kempski, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 27, 2021
Construct validity of the anglicised FACE-Q skin cancer moduleT D Dobbs, C J Harrison, M J Ottenhof, et al.
Leukemia|January 1, 1995
Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study groupH Behrendt, C Charrin, B Gibbons, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Leukemia|September 27, 2008
A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietinL J Russell, D G De Castro, M Griffiths, et al.
Leukemia|May 3, 2013
Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factorA Enshaei, C J Schwab, Z J Konn, et al.
Cancer Genetics and Cytogenetics|January 20, 2000
Multiplex fluorescence in situ hybridization and cross species color banding of a case of chronic myeloid leukemia in blastic crisis with a complex Philadelphia translocationC J Harrison, B Gibbons, F Yang, et al.
Leukemia|December 20, 2013
High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcomeL Chilton, G Buck, C J Harrison, et al.
British Journal of Haematology|October 16, 1999
A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working PartiesK Wheatley, A K Burnett, A H Goldstone, et al.
Leukemia|November 24, 2005
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trialsB E S Gibson, K Wheatley, I M Hann, et al.
Leukemia|May 1, 1992
Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemiaL M Secker-Walker, R Berger, P Fenaux, et al.
Leukemia|May 3, 2002
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working partyJ M Chessells, C J Harrison, H Kempski, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 27, 2021
Construct validity of the anglicised FACE-Q skin cancer moduleT D Dobbs, C J Harrison, M J Ottenhof, et al.
Leukemia|January 1, 1995
Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study groupH Behrendt, C Charrin, B Gibbons, et al.
Pageof 20